Thus, with all the available evidence to date, we suggest that the therapeutic potential of UCP1-positive mitochondria in combating obesity and its metabolic complications will likely be realized in humans by the acute activation of existing BAT and/or the expansion of BAT depots. The gene discussed is UCP1; the disease is obesity disorder.